Friday, October 25, 2013 9:03:31 AM
Specifically, the article confirms too...that BD is doing the future Phase 2 testing; however, I don't recall that Geralds PR ever confirmed who was doing the next set of testing (which was a very big miss on his part).
In terms of Wall Street; companies need to spin the PR to capture an audience properly. The Zacks (Jason Napodano) and Seeking Alpha folks did a nice job to bring further detail and clarification to marketplace (regarding Lympro and the potential of MANF).
Lastly, I really do think the PPS is a strong buy down here at $.05; and that assumes that the investor/investors who did the most recent financing tranche have unloaded majority of their shares (which they would have still booked a very nice profit).
GLTA!!!
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM